5 February 2022 - The COVD-19 pandemic has shown in bold relief our lack of national preparedness in the realm of public health emergencies.
As the current pandemic evolves, we need to be prepared for more twists and turns with new variants emerging. This will require at least two essential ingredients: a clear vision of the types of medical interventions needed and leaders who are empowered to refine and execute that vision.
That is why it is urgent to confirm a commissioner for the U.S. FDA.